Published in Diabetes Metab on April 01, 2005
The roles of glycated albumin as intermediate glycation index and pathogenic protein. Diabetes Metab J (2012) 1.09
Lifestyle advice follow-up improve glycemic control, redox and inflammatory status in patients with type 2 diabetes. J Diabetes Metab Disord (2014) 0.83
Protein antioxidant response to the stress and the relationship between molecular structure and antioxidant function. PLoS One (2010) 0.81
Albumin antioxidant response to stress in diabetic nephropathy progression. PLoS One (2014) 0.80
Arg354 in the catalytic centre of bovine liver catalase is protected from methylglyoxal-mediated glycation. BMC Res Notes (2015) 0.75
End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis (1999) 3.00
Policy interventions that attract nurses to rural areas: a multicountry discrete choice experiment. Bull World Health Organ (2010) 2.17
Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J (2000) 1.89
One-year efficacy and safety of Web-based follow-up using cellular phone in type 1 diabetic patients under insulin pump therapy: the PumpNet study. Diabetes Metab (2007) 1.88
Prevention of preterm births: a perinatal study in Haguenau, France. Pediatrics (1985) 1.78
Treatment of diversion colitis by short-chain fatty acids. Prospective and double-blind study. Dis Colon Rectum (1991) 1.65
Tracking of airborne radionuclides from the damaged Fukushima Dai-ichi nuclear reactors by European networks. Environ Sci Technol (2011) 1.61
Early disturbances of ambulatory blood pressure load in normotensive type I diabetic patients with microalbuminuria. Diabetes Care (1992) 1.48
Angiogenesis and biomarkers of cardiovascular risk in adults with metabolic syndrome. J Intern Med (2010) 1.48
Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)- octadecatrienoic acids from alpha-linolenic acid. J Biol Chem (1995) 1.45
Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest (1997) 1.40
Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes. Eur J Biochem (1993) 1.38
Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing. Diabet Med (2008) 1.38
Involvement of arginine 120, glutamate 524, and tyrosine 355 in the binding of arachidonate and 2-phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1. J Biol Chem (1996) 1.35
Improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients. Diabet Med (2001) 1.31
Fastigial efferent projections in the monkey: an autoradiographic study. J Comp Neurol (1977) 1.29
Acute myocardial infarction in dogs with experimental diabetes. Cardiovasc Res (1993) 1.28
A simple and efficient method for platelet isolation from their plasma. Thromb Res (1980) 1.26
Requirement and role of arachidonic acid in the differentiation of pre-adipose cells. Biochem J (1989) 1.25
Glucagon gene regulatory region directs oncoprotein expression to neurons and pancreatic alpha cells. Neuron (1988) 1.24
Effects of metformin on lactate uptake and gluconeogenesis in the perfused rat liver. Diabetes (1997) 1.20
Diabetes and inflammation: fundamental aspects and clinical implications. Diabetes Metab (2010) 1.19
Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care (2000) 1.17
Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care (1999) 1.17
Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [(13)C]DHA in phosphatidylcholine. J Lipid Res (1999) 1.15
Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes. Free Radic Biol Med (2005) 1.15
The phospholipid and fatty acid composition of human platelet surface and intracellular membranes isolated by high voltage free flow electrophoresis. J Biol Chem (1982) 1.12
13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX. J Biol Chem (1985) 1.11
Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valerylsalicylic acid. Arch Biochem Biophys (1995) 1.11
Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis. The Diabiopsies Group. J Am Soc Nephrol (1999) 1.10
Retroconversion and metabolism of [13C]22:6n-3 in humans and rats after intake of a single dose of [13C]22:6n-3-triacylglycerols. Am J Clin Nutr (1996) 1.09
Localisation of phospholipase A2 and diglyceride lipase activities in human platelet intracellular membranes. FEBS Lett (1981) 1.08
Vitamin E improves the free radical defense system potential and insulin sensitivity of rats fed high fructose diets. J Nutr (1997) 1.06
Preferential incorporation of sn-2 lysoPC DHA over unesterified DHA in the young rat brain. Am J Physiol (1994) 1.06
Lipid peroxidation in insulin-dependent diabetic patients with early retina degenerative lesions: effects of an oral zinc supplementation. Eur J Clin Nutr (1995) 1.06
Covalent modifications of aminophospholipids by 4-hydroxynonenal. Free Radic Biol Med (1998) 1.05
Analysis of intrachromosomal homologous recombination in mammalian cell, using tandem repeat sequences. Mutat Res (1999) 1.05
Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation. Biochem Pharmacol (1999) 1.05
An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats. Diabetes (1999) 1.04
Human plasma albumin transports [13C]docosahexaenoic acid in two lipid forms to blood cells. J Lipid Res (1997) 1.04
The cAMP-specific phosphodiesterase PDE4D3 is regulated by phosphatidic acid binding. Consequences for cAMP signaling pathway and characterization of a phosphatidic acid binding site. J Biol Chem (2000) 1.04
Role of the cyclic adenosine 3',5'-monophosphate and the phosphatidylinositol-Ca2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices. J Clin Endocrinol Metab (1994) 1.04
Unsaturated fatty acids esterified in 2-acyl-l-lysophosphatidylcholine bound to albumin are more efficiently taken up by the young rat brain than the unesterified form. J Neurochem (1992) 1.03
Pattern of protein phosphorylation in aortic endothelial cells. Modulation by adenine nucleotides and bradykinin. J Biol Chem (1988) 1.03
Platelets mediate the action of diethylcarbamazine on microfilariae. Nature (1987) 1.02
Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives. Diabetes Metab (2007) 1.02
Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina. Arch Biochem Biophys (1999) 1.01
Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation. FEBS Lett (2009) 1.01
Influence of metabolic disturbances of diabetes mellitus on serum CA 19-9 tumor marker. Diabete Metab (1991) 1.00
Inhibition of gluconeogenesis in isolated rat hepatocytes after chronic treatment with phenobarbital. Biochem J (1991) 0.99
Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus. Thromb Res (1980) 0.99
Covalent binding of 15-deoxy-delta12,14-prostaglandin J2 to PPARgamma. Biochem Biophys Res Commun (2005) 0.98
Immunohistochemical study of 100 pancreatic tumors in 28 patients with multiple endocrine neoplasia, type I. Am J Surg Pathol (1996) 0.98
Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations. Diabetes Metab (2004) 0.97
Earlier triple therapy with pioglitazone in patients with type 2 diabetes. Diabetes Obes Metab (2009) 0.97
Multicenter randomized evaluation of a nutritional education software in obese patients. Diabetes Metab (2001) 0.96
Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation. Biochem Pharmacol (1994) 0.95
Thrombocytopenia, macrothrombocytopathia, nephritis and deafness. Am J Med (1976) 0.95
Hydroxy-alkenals from the peroxidation of n-3 and n-6 fatty acids and urinary metabolites. Prostaglandins Leukot Essent Fatty Acids (2006) 0.95
The lipid peroxidation end-product 4-HNE induces COX-2 expression through p38MAPK activation in 3T3-L1 adipose cell. FEBS Lett (2007) 0.95
Protection of pancreatic INS-1 β-cells from glucose- and fructose-induced cell death by inhibiting mitochondrial permeability transition with cyclosporin A or metformin. Cell Death Dis (2011) 0.94
Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine and rat pancreatic islets. Diabetologia (1998) 0.94
Angio-oedema induced by dual dipeptidyl peptidase inhibitor and angiotensin II receptor blocker: a first case report. Diabet Med (2010) 0.94
Meta-analysis of genome-wide association studies identifies common variants in CTNNA2 associated with excitement-seeking. Transl Psychiatry (2011) 0.93
Myocardial β(2) -adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure. Br J Pharmacol (2012) 0.93
Initiating oral glucose-lowering therapy with metformin in type 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complications. Diabetes Metab (2004) 0.92
Tuberculosis clinics. Am J Respir Crit Care Med (1994) 0.92
Neuro-endocrine disorders seen as triggers of the triad: obesity--insulin resistance--abnormal glucose tolerance. Diabetes Metab Rev (1985) 0.92
Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products. Free Radic Biol Med (1998) 0.92
Protective effect of docosahexaenoic acid against hydrogen peroxide-induced oxidative stress in human lymphocytes. Biochem Pharmacol (1999) 0.91
The formation of tubular structures by endothelial cells is under the control of fibrinolysis and mechanical factors. Angiogenesis (1998) 0.91
Stereospecific inhibition of PGH2-induced platelet aggregation by lipoxygenase products of icosaenoic acids. Biochem Biophys Res Commun (1983) 0.91
Docosahexaenoic acid is a major n-3 polyunsaturated fatty acid in bovine retinal microvessels. J Neurochem (1996) 0.90
12-HETE inhibits the binding of PGH2/TXA2 receptor ligands in human platelets. Thromb Res (1991) 0.90
High prevalence of obstructive sleep apnoea syndrome in a Type 1 diabetic adult population: a pilot study. Diabet Med (2010) 0.90
Metabolic fate of an oral tracer dose of [13C]docosahexaenoic acid triglycerides in the rat. Am J Physiol (1996) 0.89
LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets. Diabetologia (2011) 0.89
Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid. Thromb Res (1984) 0.89
Role of lipoxygenase products in platelet function: relation to fatty acid modified phospholipids. Adv Exp Med Biol (1985) 0.88
Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents. Mol Pharmacol (1993) 0.88
Action of metformin on erythrocyte membrane fluidity in vitro and in vivo. Eur J Pharmacol (1997) 0.88
Aldehydes from n-6 fatty acid peroxidation. Effects on aminophospholipids. Prostaglandins Leukot Essent Fatty Acids (2002) 0.87
Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome. Eur Respir J (2008) 0.87
TB reporting. Public Health Rep (1998) 0.87
Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes. J Mol Cell Cardiol (1996) 0.87
How do patients with type 2 diabetes perceive their disease? Insights from the French DIABASIS survey. Diabetes Metab (2009) 0.87
Selenium supplementation decreases nuclear factor-kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients. Eur J Clin Invest (2004) 0.87
Mitochondrial H2O2 production is reduced with acute and chronic eccentric exercise in rat skeletal muscle. Antioxid Redox Signal (2006) 0.87
Stable isotope tracer and gas-chromatography combustion isotope ratio mass spectrometry to study the in vivo compartmental metabolism of docosahexaenoic acid. Anal Biochem (1994) 0.87
Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. Thromb Res (1988) 0.86
Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation. Biochem J (1997) 0.86